<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>10354644</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">37475733</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">10354644</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.3389/fneur.2023.1199251</article-id></all-ids><extracted-table><table-id>tab1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics of TAO patients and HCs.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tab1"><label>Table 1</label><caption><p>Demographic and clinical characteristics of TAO patients and HCs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Characteristics</th><th align="center" valign="top" rowspan="1" colspan="1">AP</th><th align="center" valign="top" rowspan="1" colspan="1">IP</th><th align="center" valign="top" rowspan="1" colspan="1">HC</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex (male/female)</td><td align="center" valign="middle" rowspan="1" colspan="1">12/12</td><td align="center" valign="middle" rowspan="1" colspan="1">12/14</td><td align="center" valign="middle" rowspan="1" colspan="1">13/14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.964</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (year)</td><td align="center" valign="middle" rowspan="1" colspan="1">47.42 ± 9.46</td><td align="center" valign="middle" rowspan="1" colspan="1">47.31 ± 10.71</td><td align="center" valign="middle" rowspan="1" colspan="1">47 ± 14.77</td><td align="center" valign="middle" rowspan="1" colspan="1">0.965</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Years of education (year)</td><td align="center" valign="middle" rowspan="1" colspan="1">12.13 ± 4.08</td><td align="center" valign="middle" rowspan="1" colspan="1">11.92 ± 3.25</td><td align="center" valign="middle" rowspan="1" colspan="1">12.22 ± 3.46</td><td align="center" valign="middle" rowspan="1" colspan="1">0.955</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Disease duration (year)</td><td align="center" valign="middle" rowspan="1" colspan="1">18.75 ± 19.95</td><td align="center" valign="middle" rowspan="1" colspan="1">22.23 ± 28.28</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.606</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Smoking score</td><td align="center" valign="middle" rowspan="1" colspan="1">90.83 ± 184.66</td><td align="center" valign="middle" rowspan="1" colspan="1">64.62 ± 165.09</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.766</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Antithyroid therapy (yes/no)</td><td align="center" valign="middle" rowspan="1" colspan="1">17/7</td><td align="center" valign="middle" rowspan="1" colspan="1">20/6</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.624</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Restoration of euthyroidism (yes/no)</td><td align="center" valign="middle" rowspan="1" colspan="1">8/16</td><td align="center" valign="middle" rowspan="1" colspan="1">13/13</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.233</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TSH (mIU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.59 ± 2.09</td><td align="center" valign="middle" rowspan="1" colspan="1">2.81 ± 4.11</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.180</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">fT3 (pmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.33 ± 1.73</td><td align="center" valign="middle" rowspan="1" colspan="1">3.84 ± 1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.207</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">fT4 (pmol/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.82 ± 7.14</td><td align="center" valign="middle" rowspan="1" colspan="1">5.74 ± 6.63</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.892</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TRAb (IU/L)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.67 ± 14.08</td><td align="center" valign="middle" rowspan="1" colspan="1">7.23 ± 7.83</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.035<sup>*</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Diplopia score</td><td align="center" valign="middle" rowspan="1" colspan="1">1.71 ± 1.17</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23 ± 1.25</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.163</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BCVA</td><td align="center" valign="middle" rowspan="1" colspan="1">0.84 ± 0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.91 ± 0.14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.96 ± 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">0.013<sup>*</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IOP (mmHg)</td><td align="center" valign="middle" rowspan="1" colspan="1">20.27 ± 3.77</td><td align="center" valign="middle" rowspan="1" colspan="1">18.43 ± 3.54</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.052</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Exophthalmos (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">21.69 ± 2.47</td><td align="center" valign="middle" rowspan="1" colspan="1">19.87 ± 2.8</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.058</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CAS</td><td align="center" valign="middle" rowspan="1" colspan="1">3.54 ± 1.29</td><td align="center" valign="middle" rowspan="1" colspan="1">1.08 ± 0.96</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001<sup>*</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lid aperture (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">9.94 ± 2.18</td><td align="center" valign="middle" rowspan="1" colspan="1">10.98 ± 1.65</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.029<sup>*</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Eye motility score</td><td align="center" valign="middle" rowspan="1" colspan="1">1.67 ± 0.47</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19 ± 0.92</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.059</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GO-QoL: visual functioning</td><td align="center" valign="middle" rowspan="1" colspan="1">41.42 ± 26.79</td><td align="center" valign="middle" rowspan="1" colspan="1">60.36 ± 31.26</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.032<sup>*</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GO-QoL: appearance</td><td align="center" valign="middle" rowspan="1" colspan="1">61.72 ± 25.47</td><td align="center" valign="middle" rowspan="1" colspan="1">50.86 ± 18.1</td><td align="center" valign="middle" rowspan="1" colspan="1">/</td><td align="center" valign="middle" rowspan="1" colspan="1">0.191</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HARS</td><td align="center" valign="middle" rowspan="1" colspan="1">11.54 ± 8.05</td><td align="center" valign="middle" rowspan="1" colspan="1">10.35 ± 7.12</td><td align="center" valign="middle" rowspan="1" colspan="1">2.19 ± 2.55</td><td align="center" valign="middle" rowspan="1" colspan="1">&lt;0.001<sup>*</sup></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDRS</td><td align="center" valign="middle" rowspan="1" colspan="1">6.29 ± 5.91</td><td align="center" valign="middle" rowspan="1" colspan="1">3.58 ± 3.4</td><td align="center" valign="middle" rowspan="1" colspan="1">2.52 ± 1.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.004<sup>*</sup></td></tr></tbody></table><table-wrap-foot><p>Continuous variables are presented as the mean (± standard deviation) or as the median (interquartile range). Categorical variables are presented as the number (%) and counts. TAO, thyroid-associated ophthalmopathy; AP, active TAO patients; IP, inactive TAO patients; HC, healthy controls; TSH, thyroid-stimulating hormone; fT3, free triiodothyronine; fT4, free thyroxine; TRAb, Thyroid-Stimulating Hormone Receptor Antibodies; BCVA, best corrected visual acuity; IOP, intraocular pressure; CAS, clinical activity score; GO-QOL, quality of life in thyroid eye disease; HARS, Hamilton anxiety scale; HDRS, Hamilton depression scale. *<italic>P</italic> &lt;0.05.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of TAO patients and HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Characteristics</th><th align="center" valign="top">AP</th><th align="center" valign="top">IP</th><th align="center" valign="top">HC</th><th align="center" valign="top">P-value</th></tr></thead><tbody><tr><td align="left" valign="middle">Sex (male/female)</td><td align="center" valign="middle">12/12</td><td align="center" valign="middle">12/14</td><td align="center" valign="middle">13/14</td><td align="center" valign="middle">0.964</td></tr><tr><td align="left" valign="middle">Age (year)</td><td align="center" valign="middle">47.42 ± 9.46</td><td align="center" valign="middle">47.31 ± 10.71</td><td align="center" valign="middle">47 ± 14.77</td><td align="center" valign="middle">0.965</td></tr><tr><td align="left" valign="middle">Years of education (year)</td><td align="center" valign="middle">12.13 ± 4.08</td><td align="center" valign="middle">11.92 ± 3.25</td><td align="center" valign="middle">12.22 ± 3.46</td><td align="center" valign="middle">0.955</td></tr><tr><td align="left" valign="middle">Disease duration (year)</td><td align="center" valign="middle">18.75 ± 19.95</td><td align="center" valign="middle">22.23 ± 28.28</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.606</td></tr><tr><td align="left" valign="middle">Smoking score</td><td align="center" valign="middle">90.83 ± 184.66</td><td align="center" valign="middle">64.62 ± 165.09</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.766</td></tr><tr><td align="left" valign="middle">Antithyroid therapy (yes/no)</td><td align="center" valign="middle">17/7</td><td align="center" valign="middle">20/6</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.624</td></tr><tr><td align="left" valign="middle">Restoration of euthyroidism (yes/no)</td><td align="center" valign="middle">8/16</td><td align="center" valign="middle">13/13</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.233</td></tr><tr><td align="left" valign="middle">TSH (mIU/L)</td><td align="center" valign="middle">1.59 ± 2.09</td><td align="center" valign="middle">2.81 ± 4.11</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.180</td></tr><tr><td align="left" valign="middle">fT3 (pmol/L)</td><td align="center" valign="middle">4.33 ± 1.73</td><td align="center" valign="middle">3.84 ± 1.4</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.207</td></tr><tr><td align="left" valign="middle">fT4 (pmol/L)</td><td align="center" valign="middle">5.82 ± 7.14</td><td align="center" valign="middle">5.74 ± 6.63</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.892</td></tr><tr><td align="left" valign="middle">TRAb (IU/L)</td><td align="center" valign="middle">13.67 ± 14.08</td><td align="center" valign="middle">7.23 ± 7.83</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.035*</td></tr><tr><td align="left" valign="middle">Diplopia score</td><td align="center" valign="middle">1.71 ± 1.17</td><td align="center" valign="middle">1.23 ± 1.25</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.163</td></tr><tr><td align="left" valign="middle">BCVA</td><td align="center" valign="middle">0.84 ± 0.15</td><td align="center" valign="middle">0.91 ± 0.14</td><td align="center" valign="middle">0.96 ± 0.07</td><td align="center" valign="middle">0.013*</td></tr><tr><td align="left" valign="middle">IOP (mmHg)</td><td align="center" valign="middle">20.27 ± 3.77</td><td align="center" valign="middle">18.43 ± 3.54</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.052</td></tr><tr><td align="left" valign="middle">Exophthalmos (mm)</td><td align="center" valign="middle">21.69 ± 2.47</td><td align="center" valign="middle">19.87 ± 2.8</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.058</td></tr><tr><td align="left" valign="middle">CAS</td><td align="center" valign="middle">3.54 ± 1.29</td><td align="center" valign="middle">1.08 ± 0.96</td><td align="center" valign="middle">/</td><td align="center" valign="middle">&lt;0.001*</td></tr><tr><td align="left" valign="middle">Lid aperture (mm)</td><td align="center" valign="middle">9.94 ± 2.18</td><td align="center" valign="middle">10.98 ± 1.65</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.029*</td></tr><tr><td align="left" valign="middle">Eye motility score</td><td align="center" valign="middle">1.67 ± 0.47</td><td align="center" valign="middle">1.19 ± 0.92</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.059</td></tr><tr><td align="left" valign="middle">GO-QoL: visual functioning</td><td align="center" valign="middle">41.42 ± 26.79</td><td align="center" valign="middle">60.36 ± 31.26</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.032*</td></tr><tr><td align="left" valign="middle">GO-QoL: appearance</td><td align="center" valign="middle">61.72 ± 25.47</td><td align="center" valign="middle">50.86 ± 18.1</td><td align="center" valign="middle">/</td><td align="center" valign="middle">0.191</td></tr><tr><td align="left" valign="middle">HARS</td><td align="center" valign="middle">11.54 ± 8.05</td><td align="center" valign="middle">10.35 ± 7.12</td><td align="center" valign="middle">2.19 ± 2.55</td><td align="center" valign="middle">&lt;0.001*</td></tr><tr><td align="left" valign="middle">HDRS</td><td align="center" valign="middle">6.29 ± 5.91</td><td align="center" valign="middle">3.58 ± 3.4</td><td align="center" valign="middle">2.52 ± 1.03</td><td align="center" valign="middle">0.004*</td></tr></tbody></table></div>Continuous variables are presented as the mean (± standard deviation) or as the median (interquartile range). Categorical variables are presented as the number (%) and counts. TAO, thyroid-associated ophthalmopathy; AP, active TAO patients; IP, inactive TAO patients; HC, healthy controls; TSH, thyroid-stimulating hormone; fT3, free triiodothyronine; fT4, free thyroxine; TRAb, Thyroid-Stimulating Hormone Receptor Antibodies; BCVA, best corrected visual acuity; IOP, intraocular pressure; CAS, clinical activity score; GO-QOL, quality of life in thyroid eye disease; HARS, Hamilton anxiety scale; HDRS, Hamilton depression scale. *P &lt;0.05.</transformed-table></extracted-table><extracted-table><table-id>tab2</table-id><table-label>Table 2</table-label><table-caption>Brain areas with significantly different ALFF/fALFF and FC values between groups (voxel P &lt; 0.001, cluster P &lt; 0.05, cluster-level GRF corrected).</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tab2"><label>Table 2</label><caption><p>Brain areas with significantly different ALFF/fALFF and FC values between groups (voxel <italic>P</italic> &lt; 0.001, cluster <italic>P</italic> &lt; 0.05, cluster-level GRF corrected).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2" colspan="1">Parameter</th><th align="center" valign="top" rowspan="2" colspan="1">Brain regions</th><th align="center" valign="top" rowspan="2" colspan="1">F-value</th><th align="center" valign="top" rowspan="2" colspan="1">Cluster size</th><th align="left" valign="top" colspan="3" rowspan="1">MNI coordinates of peak voxel</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">X</th><th align="center" valign="top" rowspan="1" colspan="1">Y</th><th align="center" valign="top" rowspan="1" colspan="1">Z</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALFF</td><td align="center" valign="middle" rowspan="1" colspan="1">Calcarine_R</td><td align="center" valign="middle" rowspan="1" colspan="1">12.3896</td><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">−63</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALFF</td><td align="center" valign="middle" rowspan="1" colspan="1">Caudate_R</td><td align="center" valign="middle" rowspan="1" colspan="1">14.0245</td><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">−9</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">−3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALFF</td><td align="center" valign="middle" rowspan="1" colspan="1">Postcentral_L</td><td align="center" valign="middle" rowspan="1" colspan="1">12.0832</td><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">−57</td><td align="center" valign="middle" rowspan="1" colspan="1">−3</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">fALFF</td><td align="center" valign="middle" rowspan="1" colspan="1">Cerebelum_Crus1_R</td><td align="center" valign="middle" rowspan="1" colspan="1">14.1279</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">−39</td><td align="center" valign="middle" rowspan="1" colspan="1">−84</td><td align="center" valign="middle" rowspan="1" colspan="1">−33</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FC</td><td align="center" valign="middle" rowspan="1" colspan="1">Postcentral_L</td><td align="center" valign="middle" rowspan="1" colspan="1">12.4138</td><td align="center" valign="middle" rowspan="1" colspan="1">51</td><td align="center" valign="middle" rowspan="1" colspan="1">−51</td><td align="center" valign="middle" rowspan="1" colspan="1">−6</td><td align="center" valign="middle" rowspan="1" colspan="1">36</td></tr></tbody></table><table-wrap-foot><p>ALFF, amplitude of low-frequency fluctuations; fALFF, fractional amplitude of low-frequency fluctuation; GRF, Gaussian random field; MNI, Montreal Neurologic Institute; FC, functional connectivity.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Brain areas with significantly different ALFF/fALFF and FC values between groups (voxel P &lt; 0.001, cluster P &lt; 0.05, cluster-level GRF corrected).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="2">Parameter</th><th align="center" valign="top" rowspan="2">Brain regions</th><th align="center" valign="top" rowspan="2">F-value</th><th align="center" valign="top" rowspan="2">Cluster size</th><th align="left" valign="top" colspan="3">MNI coordinates of peak voxel</th></tr><tr><th align="center" valign="top">X</th><th align="center" valign="top">Y</th><th align="center" valign="top">Z</th></tr></thead><tbody><tr><td align="left" valign="middle">ALFF</td><td align="center" valign="middle">Calcarine_R</td><td align="center" valign="middle">12.3896</td><td align="center" valign="middle">15</td><td align="center" valign="middle">6</td><td align="center" valign="middle">−63</td><td align="center" valign="middle">12</td></tr><tr><td align="left" valign="middle">ALFF</td><td align="center" valign="middle">Caudate_R</td><td align="center" valign="middle">14.0245</td><td align="center" valign="middle">37</td><td align="center" valign="middle">−9</td><td align="center" valign="middle">12</td><td align="center" valign="middle">−3</td></tr><tr><td align="left" valign="middle">ALFF</td><td align="center" valign="middle">Postcentral_L</td><td align="center" valign="middle">12.0832</td><td align="center" valign="middle">23</td><td align="center" valign="middle">−57</td><td align="center" valign="middle">−3</td><td align="center" valign="middle">21</td></tr><tr><td align="left" valign="middle">fALFF</td><td align="center" valign="middle">Cerebelum_Crus1_R</td><td align="center" valign="middle">14.1279</td><td align="center" valign="middle">20</td><td align="center" valign="middle">−39</td><td align="center" valign="middle">−84</td><td align="center" valign="middle">−33</td></tr><tr><td align="left" valign="middle">FC</td><td align="center" valign="middle">Postcentral_L</td><td align="center" valign="middle">12.4138</td><td align="center" valign="middle">51</td><td align="center" valign="middle">−51</td><td align="center" valign="middle">−6</td><td align="center" valign="middle">36</td></tr></tbody></table></div>ALFF, amplitude of low-frequency fluctuations; fALFF, fractional amplitude of low-frequency fluctuation; GRF, Gaussian random field; MNI, Montreal Neurologic Institute; FC, functional connectivity.</transformed-table></extracted-table></extracted-tables-set>